MustGrow Biologics Statistics

Total Valuation

MGROF has a market cap or net worth of 30.63 million. The enterprise value is 31.45 million.

Market Cap	30.63M
Enterprise Value	31.45M

Important Dates

The next estimated earnings date is Tuesday, August 26, 2025.

Earnings Date	Aug 26, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	52.39M
Shares Outstanding	n/a
Shares Change (YoY)	+3.82%
Shares Change (QoQ)	+5.88%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	45.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.53
PB Ratio	67.45
P/TBV Ratio	571.06
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-8.23
EV / Sales	10.30
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.28

Financial Position

The company has a current ratio of 1.68, with a Debt / Equity ratio of 4.82.

Current Ratio	1.68
Quick Ratio	0.91
Debt / Equity	4.82
Debt / EBITDA	n/a
Debt / FCF	-0.51
Interest Coverage	-111.73

Financial Efficiency

Return on equity (ROE) is -205.53% and return on invested capital (ROIC) is -64.65%.

Return on Equity (ROE)	-205.53%
Return on Assets (ROA)	-45.68%
Return on Invested Capital (ROIC)	-64.65%
Return on Capital Employed (ROCE)	-143.30%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.64
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.08% in the last 52 weeks. The beta is 2.31, so MGROF's price volatility has been higher than the market average.

Beta (5Y)	2.31
52-Week Price Change	-10.08%
50-Day Moving Average	0.73
200-Day Moving Average	0.92
Relative Strength Index (RSI)	33.32
Average Volume (20 Days)	1,131

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MGROF had revenue of 2.91 million and -3.82 million in losses. Loss per share was -0.07.

Revenue	2.91M
Gross Profit	387,878
Operating Income	-3.33M
Pretax Income	-3.82M
Net Income	-3.82M
EBITDA	n/a
EBIT	-3.33M
Loss Per Share	-0.07

Full Income Statement

Balance Sheet

The company has 1.41 million in cash and 2.19 million in debt, giving a net cash position of -783,533.

Cash & Cash Equivalents	1.41M
Total Debt	2.19M
Net Cash	-783,533
Net Cash Per Share	n/a
Equity (Book Value)	454,077
Book Value Per Share	0.01
Working Capital	1.77M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.31 million and capital expenditures -7,525, giving a free cash flow of -4.32 million.

Operating Cash Flow	-4.31M
Capital Expenditures	-7,525
Free Cash Flow	-4.32M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 13.34%, with operating and profit margins of -114.49% and -131.46%.

Gross Margin	13.34%
Operating Margin	-114.49%
Pretax Margin	-131.46%
Profit Margin	-131.46%
EBITDA Margin	n/a
EBIT Margin	-114.49%
FCF Margin	n/a

Dividends & Yields

MGROF does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.82%
Shareholder Yield	-3.82%
Earnings Yield	-12.48%
FCF Yield	-14.10%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MGROF has an Altman Z-Score of -1.36. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.36
Piotroski F-Score	n/a